BlackRock’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.2B Buy
5,399,649
+228,883
+4% +$114M 0.06% 291
2025
Q4
$2.52B Sell
5,170,766
-182,230
-3% -$84.9M 0.04% 342
2025
Q3
$2.24B Buy
5,352,996
+19,288
+0.4% +$6.49M 0.04% 375
2025
Q2
$1.53B Sell
5,333,708
-112,384
-2% -$33.6M 0.03% 482
2025
Q1
$1.68B Buy
5,446,092
+87,760
+2% +$30.1M 0.04% 432
2024
Q4
$1.89B Buy
5,358,332
+40,935
+0.8% +$15M 0.04% 400
2024
Q3
$1.91B Sell
5,317,397
-151,617
-3% -$51.2M 0.04% 397
2024
Q2
$1.74B Sell
5,469,014
-98,516
-2% -$26.1M 0.04% 393
2024
Q1
$1.28B Buy
5,567,530
+272,530
+5% +$61.5M 0.03% 511
2023
Q4
$1.16B Buy
5,295,000
+183,395
+4% +$42.3M 0.03% 516
2023
Q3
$1.15B Buy
5,111,605
+14,920
+0.3% +$3.44M 0.03% 478
2023
Q2
$1.13B Buy
5,096,685
+344,724
+7% +$76.4M 0.03% 493
2023
Q1
$1.06B Buy
4,751,961
+241,594
+5% +$59.6M 0.03% 520
2022
Q4
$1.25B Buy
4,510,367
+182,999
+4% +$46.2M 0.04% 436
2022
Q3
$906M Buy
4,327,368
+13,196
+0.3% +$2.95M 0.03% 521
2022
Q2
$1.02B Buy
4,314,172
+37,083
+0.9% +$7.54M 0.03% 508
2022
Q1
$767M Buy
4,277,089
+37,914
+0.9% +$7.22M 0.02% 700
2021
Q4
$916M Sell
4,239,175
-66,613
-2% -$13.1M 0.02% 648
2021
Q3
$795M Sell
4,305,788
-24,959
-0.6% -$4.92M 0.02% 677
2021
Q2
$777M Sell
4,330,747
-82,180
-2% -$15.7M 0.02% 718
2021
Q1
$738M Buy
4,412,927
+139,803
+3% +$23.3M 0.02% 738
2020
Q4
$649M Sell
4,273,124
-32,393
-0.8% -$4.25M 0.02% 725
2020
Q3
$435M Sell
4,305,517
-215,439
-5% -$23.6M 0.02% 828
2020
Q2
$547M Buy
4,520,956
+62,548
+1% +$7.04M 0.02% 660
2020
Q1
$423M Sell
4,458,408
-182,677
-4% -$17.4M 0.02% 698
2019
Q4
$409M Buy
4,641,085
+218,875
+5% +$19.3M 0.02% 951
2019
Q3
$353M Sell
4,422,210
-70,457
-2% -$5.67M 0.01% 1002
2019
Q2
$351M Sell
4,492,667
-502,092
-10% -$47M 0.02% 1019
2019
Q1
$586M Buy
4,994,759
+52,760
+1% +$6.15M 0.03% 639
2018
Q4
$538M Buy
4,941,999
+18,834
+0.4% +$2.18M 0.03% 608
2018
Q3
$630M Sell
4,923,165
-104,893
-2% -$13M 0.03% 624
2018
Q2
$569M Buy
5,028,058
+115,073
+2% +$12.6M 0.03% 646
2018
Q1
$552M Buy
4,912,985
+141,416
+3% +$18M 0.03% 638
2017
Q4
$706M Sell
4,771,569
-30,050
-0.6% -$3.82M 0.03% 531
2017
Q3
$563M Sell
4,801,619
-95,715
-2% -$12.2M 0.03% 594
2017
Q2
$635M Buy
4,897,334
+155,349
+3% +$19.4M 0.03% 529
2017
Q1
$642M Buy
4,741,985
+4,632,287
+4,223% +$702M 0.04% 526
2016
Q4
$15.7M Sell
109,698
-15,466
-12% -$1.97M 0.02% 615
2016
Q3
$14.8M Sell
125,164
-4,092
-3% -$492K 0.02% 621
2016
Q2
$13.7M Sell
129,256
-21,188
-14% -$2.36M 0.02% 625
2016
Q1
$16.8M Sell
150,444
-41,769
-22% -$5.29M 0.03% 560
2015
Q4
$30.1M Buy
192,213
+72,641
+61% +$10.6M 0.04% 421
2015
Q3
$15.7M Buy
119,572
+7,486
+7% +$1.2M 0.02% 549
2015
Q2
$19.5M Sell
112,086
-93,826
-46% -$16.9M 0.03% 524
2015
Q1
$35.5M Buy
205,912
+14,273
+7% +$2.18M 0.05% 399
2014
Q4
$24.8M Buy
191,639
+43,707
+30% +$5.63M 0.04% 463
2014
Q3
$19M Sell
147,932
-52,052
-26% -$5.37M 0.03% 526
2014
Q2
$17.7M Sell
199,984
-41,580
-17% -$4M 0.03% 539
2014
Q1
$22.7M Buy
241,564
+5,337
+2% +$546K 0.04% 473
2013
Q4
$26.7M Buy
236,227
+86,842
+58% +$7.83M 0.04% 417
2013
Q3
$11.8M Buy
149,385
+9,692
+7% +$708K 0.02% 574
2013
Q2
$9.2M Buy
+139,693
New +$9M 0.02% 610

Other funds holding UTHR